| Title | Author(s) | Year | View Count |  | SARS CoV subunit vaccine: antibody-mediated neutralisation and enhancement. | Jaume, M; Yip, MS; Kam, YW; Cheung, CY; Kien, F; Roberts, A; Li, PH; Dutry, I; Escriou, N; Daeron, M; Bruzzone, R; Subbarao, K; Peiris, JS; Nal, B; Altmeyer, R | 2012 | 65 |
| Investigation of Antibody-Dependent Enhancement (ADE) of SARS coronavirus infection and its role in pathogenesis of SARS | Yip, MS; Cheung, CY; Li, PH; Bruzzone, R; Peiris, JSM; Jaume, M | 2011 | 153 |
| Antibody-Dependent Enhancement (ADE) of infection and its possible role in the pathogenesis of influenza | Dutry, I; Yen, HL; Lee, H; Peiris, M; Jaume, M | 2011 | 131 |
| Antibody-Dependent Enhancement (ADE) of influenza infection and its possible role in the pathogenesis of influenza | Dutry, I; Yen, HL; Lee, H; Peiris, M; Jaume, M | 2011 | 149 |
 | Anti-severe acute respiratory syndrome coronavirus spike antibodies trigger infection of human immune cells via a pH- and cysteine protease-independent Fcγr pathway | Jaume, M; Yip, MS; Cheung, CY; Leung, HL; Li, PH; Kien, F; Dutry, I; Callendret, B; Escriou, N; Altmeyer, R; Nal, B; Daëron, M; Bruzzone, R; Peiris, JSM | 2011 | 159 |
|
